Advertisement

Adjuvant Chemotherapy and Immunotherapy in Colorectal Cancer

  • G. M. Mavligit
  • J. U. Gutterman
  • E. M. Hersh
Part of the Sloan-Kettering Institute Cancer Series book series (SKICS)

Abstract

Colorectal cancer appears to be an ever-growing epidemic with an all-time high incidence of approximately 100,000 new cases estimated in the United States during 1977. This disease, which seems to affect males and females equally, has been subjected to numerous surgical therapeutic approaches during the past two decades. Unfortunately, these exhaustive conventional approaches have failed to improve the overall prognosis (Donaldson and Welch, 1974).

Keywords

Colorectal Cancer Carcinoembryonic Antigen Advanced Colorectal Cancer Serial Determination Operable Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ambus, U., Mavligit, G. M., Gutterman, J. U., McBride, C. M., and Hersh, E. M., 1974, Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy, Int. J. Cancer 14: 291–300.PubMedCrossRefGoogle Scholar
  2. Baldwin, R. W., Embleton, M. J., Jones, J. S. P., and Langman M. J. S., 1973e, Cell-mediated and humoral immune reactions to human tumours, Int. J. Cancer 12: 73–83.PubMedCrossRefGoogle Scholar
  3. Baldwin, R. W., Embleton, M.J., and Price, M.R., 1973b, Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions, Int. J. Cancer 12: 84–92.PubMedCrossRefGoogle Scholar
  4. Beahrs, O. H., and Sanfelippo, P. M., 1971, Factors in prognosis of colon and rectal cancer, Cancer 28: 213–218.PubMedCrossRefGoogle Scholar
  5. Black, M. M., Opler, S., and Speer, F., 1955, Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes, Surg. Gynecol. Obstet. 100: 543–551.PubMedGoogle Scholar
  6. Bone, G., and Lauder,I., 1974, Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract, Br. J. Cancer 30: 215–221.PubMedCrossRefGoogle Scholar
  7. Booth, S. N., Jamieson, G. C., King, J. P. G., Leonard, J. Oates, G. D., and Dykes, P. W., 1974, Carcinoembryonic Antigen in management of colorectal carcinoma, Br. Med. J. 4:183–187.PubMedCrossRefGoogle Scholar
  8. Bowen, J. G., Robins, R. A., and Baldwin, R. W., 1975, Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth, Int. J . Cancer 15: 640–650.PubMedCrossRefGoogle Scholar
  9. Bull, D. M., Leibach, J. R.,Williams, M. A., and Helms, R. A., 1973, Immunity to colon cancer assessed by antigen-induced inhibition of mixed mononuclear cell migration, Science 181:957–959.PubMedCrossRefGoogle Scholar
  10. Collatz, E., Von Kleist, S., and Burtin, P., 1971, Further investigations of circulating antibodies in colon cancer patients: On the autoantigenticity of the carcinoembryonic antigen, Int. J. Cancer 8: 298–303.PubMedCrossRefGoogle Scholar
  11. Donaldson, G. A., and Welch, J. P., 1974, Management of cancer of the colon, Surg. Clin. N. Am. 54: 713–731.PubMedGoogle Scholar
  12. Edwards, A. J., Lee, M. R., and Rowland, G. F., 1973, Reduction of lympocyte transformation by a factor produced by gastrointestinal cancer, Lancet 1: 687–689.PubMedCrossRefGoogle Scholar
  13. Elias, E. G., and Elias, L. L., 1975, Some immunologic characteristics of carcinoma of the colon and rectum, Surg. Gynecol. Obstet. 141: 715–718.PubMedGoogle Scholar
  14. Enterline, H. T., 1975, Management of polypoid lesions, J. Am. Med. Assoc. 231: 967–969.CrossRefGoogle Scholar
  15. Falkson, G., van Eden, E. B., and Falkson, H. C., 1974, Fluorouracil, imidazole carboximide dimethyl triazeno, vincristine, and bis-chlorethyl nitrosourea in colon cancer, Cancer 33: 1207–1209.PubMedCrossRefGoogle Scholar
  16. Falterman, K. W., Hill, C. B., Markey, J. C., Fox, J. W., and Cohn, I., Jr., 1974, Cancer of the colon, rectum, and anus: A review of 2313 cases, Cancer 34: 951–959.PubMedCrossRefGoogle Scholar
  17. Gold, P., 1967, Circulating antibodies against carcinoembryonic antigens of the human digestive system, Cancer 20: 1663–1667.CrossRefGoogle Scholar
  18. Gold, P., and Freedman, S. 0., 1965, Specific carcinoembryonic antigens of the human digestive system, J. Exp. Med. 122: 467–481.PubMedCrossRefGoogle Scholar
  19. Grage, T., Cornell, G., Strawitz, J., Jonas, K., Frelick, R., and Metter, G., 1975, Adjuvant therapy with 5-FU after surgical resection of colo-rectal cancer, Proc. Am. Soc. Clin. Oncol. 16: 258.Google Scholar
  20. Guillou, P.J., Brennan, T. G., and Giles, G. R., 1975, A study of lymph nodes draining colorectal cancer using a two-stage inhibition of leucocyte migration technique, Gut 16: 290–297.PubMedCrossRefGoogle Scholar
  21. Gunderson, L. L., and Sosin, H., 1974, Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum, Cancer 34: 1278–1292.PubMedCrossRefGoogle Scholar
  22. Hellström, I. and Hellström, K. E., 1972, Newer concepts of cancer of the colon and rectum: Cellular immunity to human colonic carcinomas, Dis. Colon Rectum 15:100–105.Google Scholar
  23. Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J.-P. S., 1968; Cellular and humoral immunity to different types of human neoplasms, Nature (London) 220: 1352–1354.CrossRefGoogle Scholar
  24. Heppner, G. H., Griswold, D. E., Di Lorenzo, J., Poplin, E. A., and Calabresi, P., 1974, Selective immunosuppressive by drugs in balanced immune responses, Fed. Proc. 33: 1882–1885.PubMedGoogle Scholar
  25. Hersh, E. M., Gutterman, J. U., and Mavligit, G., 1973, Immunotherapy of Cancer in Man: Scientific Basis and Current Status, p. 141, Thomas, Springfield, Ill.Google Scholar
  26. Higgins, G. A., Dwight, R. W., Smith, J. V., and Keehn, R. J., 1971, Fluorouracil as an adjuvant to surgery in carcinoma of the colon, Arch. Surg. 102: 339–343.PubMedCrossRefGoogle Scholar
  27. Hollinshead, A., Glew, D., Bunnag, B., Gold, P., and Herberman, R., 1970, Skin-reactive soluble antigen from intestinal cancer-cell-membranes and relationship to carcinoembryonic antigens, Lancet 1:1191–1195.Google Scholar
  28. Holyoke, E. D., Ming Chu, T., and Murphy, G. P., 1975, CEA as a monitor of gastrointestinal malignancy, Cancer 35: 830–836.PubMedCrossRefGoogle Scholar
  29. House, A. K., Wisniewski, S., and Woodings, T. L., 1975, Immunity in colonic tumor patients after operation: Determination by leukocyte-migration inhibition, Dis. Colon Rectum 18:100-106.Google Scholar
  30. Kaplan, M. S., Mino, F. 0., Kummerfeld, K. B., and Lundak, R. L., 1975, Phytohemmagglutininstimulated immune response, Arch. Surg. 110:1217–1220.PubMedCrossRefGoogle Scholar
  31. Lauder, I.,and Bone, G., 1973, Lymphocyte transformation in large bowel cancer, Br. J. Cancer 27:409–413.PubMedCrossRefGoogle Scholar
  32. Lawrence, W., Jr., Terz, J. J., Horsley, S., III., Donaldson, M., Lovett, W. L., Brown, P. W., Ruffner, B. W., and Regelson, W., 1975, Chemotherapy as an adjuvant to surgery for colorectal cancer, Ann. Surg. 181:616–623.PubMedCrossRefGoogle Scholar
  33. Lejtenyi, M. C., Freedman, S. 0., and Gold, P., 1971, Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system, Cancer 28: 115–120.PubMedCrossRefGoogle Scholar
  34. Li. M. C., and Ross, S. T., 1976, Chemoprophylaxis for patients with colorectal cancer, J. Am. Med. Assoc. 235: 2825–2828.CrossRefGoogle Scholar
  35. LoGerfo, P., and Herter, F. P., 1975, Carcinoembryonic antigen and prognosis in patients with colon cancer, Ann. Surg. 181:81–84.CrossRefGoogle Scholar
  36. LoGerfo, P., Herter, F. P., and Bennett, S.J., 1972, Absence of circulating antibodies to carcinoembryonic antigen in patients with gastrointestinal malignancies, Int. J. Cancer 9: 344–348.CrossRefGoogle Scholar
  37. Lurie, B. B., Bull, D. M., Zamcheck, N., Steward, A. M., and Helms, R. A., 1975, Diagnosis and prognosis in colon cancer based on a profile of immune reactivity, J. Natl. Cancer Inst. 54: 319–325.PubMedGoogle Scholar
  38. MacGregor, A. B., Falk, R. E., Landi, S., Ambus, U., and Langer, B., 1975, Oral bacille Calmette Guérin immunostimulation in malignant melanoma, Surg. Gynecol. Obstet. 141: 747–754.PubMedGoogle Scholar
  39. MacKay, A. M., Patel, S., Carter, S., Stevens, U., Laurence, D. J. R., Cooper, E. H., and Neville, A. M., 1974, Role of serial plasma CEA assays in detection of recurrent and metastatic colorectal carcinomas, Br. Med. J. 4: 382–385.PubMedCrossRefGoogle Scholar
  40. Mackman, S., Ansfield, F. J., Ramirez, G., and Curreri, A. R., 1974, A second look at the second look operation in colonic cancer after the administration of fluorouracil, Am. J. Surg. 128: 763–766.PubMedCrossRefGoogle Scholar
  41. MacSween, J. M., 1975, The antigenicity of carcinoembryonic antigen in man, Int. J. Cancer 25: 246–252.CrossRefGoogle Scholar
  42. Magrath, I. T., Lwanga, S., Carswell, W., and Harrison, N., 1974, Surgical reduction in tumour bulk in management of abdominal Burkitt’s lymphoma, Br. Med. J. 2: 308–312.PubMedCrossRefGoogle Scholar
  43. Mavligit, G., Gutterman, J. U., McBride, C. M., and Hersh, E. M., 1972. Multifaceted evaluation of human tumor immunity using a salt extracted colon carcinoma antigen, Proc. Soc. Exp. Biol. Med. 140: 1240–1245.PubMedCrossRefGoogle Scholar
  44. Mavligit, G. M., Jubert, A. V., Gutterman, J. U., McBride, C. M., and Hersh, E. M., 1974, Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon, Surg. Gynecol. Obstet. 139:409–412.PubMedGoogle Scholar
  45. Mavligit, G. M., Gutterman, J. U., Burgess, M. A., Khankhanian, N., Seibert, G. B., Speer, J. F., Jubert, A. V., Martin, R. C., McBride, C. M., Copeland, E. M., Gehan, E. A., and Hersh, E. M., 1976, Prolongation of post operative disease free interval and survival in human colorectal cancer by bacillus-Calmette-Guérin • (BCG) or BCG plus 5-fluorouracil, Lancet 1: 871–876.PubMedCrossRefGoogle Scholar
  46. Mclllmurray, M. B., Price, M. R., and Langman, M. J. S., 1974, Inhibition of leucocyte migration in patients with large intestinal cancer by extracts prepared from large intestinal tumours and from normal colonic mucosa, Br. J. Cancer 29: 305–311.CrossRefGoogle Scholar
  47. Moertel, C. G., Ritts, R. E., Jr., Schutt, A.J., and Hahn, R. G., 1975a, Clinical studies of methanol extraction residue fraction of bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer, Cancer Res. 35: 3075–3083.PubMedGoogle Scholar
  48. Moertel, C. G., Schutt, A. J., Hahn, R. G., and Reitemeier, R. J., 1975b, Brief communication: Therapy of advanced colorectal cancer with a combination of 5-flourouracil, methyl-1,3cis(2-chlorethyl)- 1-nitrosourea, and vincristine, J. Natl. Cancer Inst. 54: 69–71.PubMedGoogle Scholar
  49. Murray, D., Hreno, A., Dutton, J., and Hampson, L. G., 1975, Prognosis in colon cancer, Arch. Surg. 110: 908–913.PubMedCrossRefGoogle Scholar
  50. Nind, A. P. P., Nairn, R. C., Rolland, J. M., Guli, E. P. G., and Hughes, E. S. R., 1973, Lymphocyte anergy in patients with carcinoma, Br. J. Cancer 28: 108–117.PubMedCrossRefGoogle Scholar
  51. Nind, A. P. P., Matthews, N., Pihl, E. A. V., Rolland, J. M., and Nairn, R. C., 1975, Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma, Br. J. Cancer 31: 620–629.PubMedCrossRefGoogle Scholar
  52. Patt, D. J., Brynes, R. K., Vardiman, J. W., and Coppleson, L. W., 1975, Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: An immumorphologic study, Cancer 35: 1388–1397.PubMedCrossRefGoogle Scholar
  53. Pihl, E., Hughes, E. S. R., Nind, A. P. P., and Nairn, R. C., 1975, Colonic carcinoma: Clinicopathological correlation with immunoreactivity, Br. Med. J. 3: 742–743.PubMedCrossRefGoogle Scholar
  54. Roswit, B., Higgins, G. A., Jr., and Keehn, R. J., 1975, Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: Report of a national Veterans Administration randomized study, Cancer 35: 1597–1602.PubMedCrossRefGoogle Scholar
  55. Rousselot, L. M., Cole, D. R., Grossi, C. E., Conte, A.J., Gonzales, E. M., and Pasternack, B. S., 1972, Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer; eight year progress report, Dis. Colon Rectum 15:169–174.Google Scholar
  56. Schabel, F. M., 1975, Concepts for systemic treatment of micrometatases, Cancer 25: 15–24.CrossRefGoogle Scholar
  57. Schultz, R. M., Woods, W. A., and Chirigos, M. A., 1975, Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum, Int. J. Cancer 16: 16–23.PubMedCrossRefGoogle Scholar
  58. Segerling, M., Ohanian, S. H., and Borsos, T., 1975, Chemotherapeutic drugs increase killing of tumor cells by antibody and complement, Science 188: 55–57.PubMedCrossRefGoogle Scholar
  59. Seitanides, B., and Georgoulis, B., 1975, Rosette-forming-lymphocyte counts in cancer of the colon, Lancet 1:461.Google Scholar
  60. Spratt, J. S., Jr., and Spjut, H. J., 1967, Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma, Cancer 20: 1976–1985.PubMedCrossRefGoogle Scholar
  61. Stearns, M. W., Jr., Deddish, M. R., Stuart, H. Q., and Learning, R. H., 1974, Preoperative roentgen therapy for cancer of the rectum and rectosigmoid, Surg. Gynecol. Obstet. 138: 584–586.PubMedGoogle Scholar
  62. Straus, E., Vernace, S., Janowitz, H., and Paronetto, F., 1975, Migration of peripheral leukocytes in the presence of carcinoembryonic antigen: Studies in patients with chronic inflammatory diseases of the intestine and carcinoma of the colon and jancreas, Proc. Soc. Exp. Biol. Med. 148: 494–497.PubMedCrossRefGoogle Scholar
  63. Thompson, D., Krupey, W., Freedman, S., and Gold, P., 1969, The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system, Proc. Natl. Acad. Sci. USA 64: 161–167.CrossRefGoogle Scholar
  64. Tsakraklides, V., Wanebo, H. J., Sternberg, S. S., Stearns, M., and Good, R. A., 1975, Prognostic evaluation of regional lymph node morphology in colorectal cancer, Am. J. Surg. 129: 174–180.PubMedCrossRefGoogle Scholar
  65. Turnbull, R. B., Jr., 1970, Cancer of the colon: The five-and ten-year survival rates following resection utilizing the isolation technique, Ann. R. Coll. Surg. Eng. 46: 243–250.Google Scholar
  66. Welch, C. E, and Burke, J. F., 1962, Carcinoma of the colon and rectum, N. Eng. J. Med. 266: 211–219.CrossRefGoogle Scholar
  67. Welch, J. P., and Donaldson, G. A., 1974, Recent experience in the management of cancer of the colon and rectum, Am. J. Surg. 127: 258–266.PubMedCrossRefGoogle Scholar
  68. Zamcheck, N., and Pusztaszeri, G., 1975, CEA, AFP and other potential tumor markers, CA 25: 204–214.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • G. M. Mavligit
    • 1
  • J. U. Gutterman
    • 1
  • E. M. Hersh
    • 1
  1. 1.Section of Immunology, Department of Developmental TherapeuticsThe University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor InstituteHoustonUSA

Personalised recommendations